Viewing nowCombinationTwinact Tablet 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.

MFDS item code 201605707 · Approved 2016.09.29 · Insurance code 678600700
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively control blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or telmisartan.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this drug; however, a direct switch to this drug may be considered if blood pressure is not controlled with the individual components as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. In patients taking telmisartan and amlodipine in combination, they may switch to this drug (a fixed-dose combination with the same amount of each active ingredient) for convenience (limited to this drug 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, it is recommended that treatment be initiated at a low dose in patients with severe renal impairment, with gradual dose increases. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
Aged 18 years or younger: Administration of this drug is not recommended because safety and efficacy have not been established.
This medication can pose a serious risk to the fetus, especially during the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. It should not be used by individuals who have allergies to the active ingredients or similar compounds, those with severe liver or heart issues, pregnant or breastfeeding women, and patients with certain kidney diseases. Patients with primary aldosteronism, valvular heart disease, poor liver function, gastrointestinal diseases, renal vascular problems, those on dialysis, and the elderly should use this medication with special caution. This medication may commonly cause dizziness or swelling in the limbs, and rarely, severe reactions or allergies, such as hypotension and liver function abnormalities, may occur; if any unusual symptoms arise, medical consultation should be sought immediately. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible and switched to another safe treatment method. Since this medication has blood pressure-lowering effects, patients with excessively low blood pressure or dehydration should consult a doctor before taking this medication, and blood pressure and kidney function should be monitored regularly during the course of treatment. Additionally, potassium levels may rise, so caution is required when taking it alongside potassium-rich foods, potassium supplements, or certain diuretics. This medication may interact with other drugs, so patients must inform their doctor or pharmacist, especially when taking heart medications, diuretics, lithium, warfarin, or non-steroidal anti-inflammatory drugs. Dizziness or drowsiness may occur when driving or operating machinery, so caution is urged. In cases of overdose, severe hypotension or heart problems may occur, and immediate medical attention is required, as this medication is not removed by dialysis, necessitating specialized treatment. When storing, keep it out of reach of children, store in a tightly sealed container, and do not transfer to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it is advisable to store it at a cool room temperature, i.e., between 1 to 30 degrees Celsius.
A white and light gray double tablet that is bilaterally convex and oval-shaped.
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
(Co., Ltd.) CMG Pharmaceutical
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.